Interview with Jan-Willem Eleveld, Vice President, Counsulting & Services,…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Address: 302, Level 3, Damansara Uptown 2, 2 Jalan SS21/37, 47400 Petaling Jaya, Selangor,Malaysia
Tel: 603 7710 7380
Web: http://www.imshealth.com/portal/site/ims
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Commercial Implementation Services: We help meet the challenges of commercial information management, with cutting-edge solutions in reporting and analytics, and operations and compensation outsourcing.
Managed Markets Services: With more than three-quarters of U.S. prescriptions underwritten by third-party payers, we’re the ones to call to help meet contracting, compliance and systems challenges.
Market Research Services: We not only deliver views of market position, but also provide related services — including outsourcing of key market research processes.
We apply Evidence-Based ConsultingSM that can have an immediate impact on the business and market performance of our clients. We help to strengthen portfolios, optimize product launches, mount superior marketing efforts, forge more productive alliances and optimize sales force structure and deployment.
Product & Portfolio Strategy
Companies that don’t plan for the future don’t have one. We help keep the compass pointed in the right direction.
Commercial Effectiveness
A surprisingly low percentage of pharmaceutical brands outperform expectations. We help clients gain access to that elite club.
Pricing & Market Access
There’s both an art and a science to launching new products and ensuring optimal market access and price. We understand the complex dynamics shaping the prospects for products in research and development as well as for those already in-market.
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
David Ho, managing director of Hovid, introduces the success story of his family-owned company, which started at a Chinese herbal tea manufacturer and became one of the biggest local generic…
Dr Goh Pik Pin, director of the Clinical Research Centre (CRC), and Dr Salina Abd Aziz, consultant psychiatrist and chairperson, MOH Medical Research Ethics Committee, and head, CRC Hospital Kuala…
Tunku Naquiyuddin and Tunku Mohamed Alauddin, respectively executive chairman and managing director of the Antah Healthcare Group highlight the importance of close business relationships between stakeholders in Malaysia and its…
Sea cucumbers – odd-looking marine animals with leathery skins and elongated bodies – can be found on ocean floors worldwide. Although more famous as a culinary delicacy in East and…
Datuk Seri Dr. Haji Dzulkefly bin Ahmad, Malaysia’s Minister of Health, sets out his vision and key priorities for healthcare in the country over the course of the new parliamentary…
Günther Beissel, CEO of the Malaysia International Trade and Exhibition Centre (MITEC), highlights the venue’s unique proposition within Malaysia’s business events industry and MITEC’s journey to become Southeast Asia’s leading…
Dr Hassan Yaakob of Healwell Pharmaceutical Co. Ltd., discusses the company’s rejuvenating and anti-ageing products, made from a polypeptide derived from sea cucumber. He also gives insights into the changing consumer…
Dr. Fadzilah Kamaludin, the director of the Institute for Medical Research (IMR) in Malaysia, highlights the important role of the IMR, as a public organization, to help the research in…
Ewe Kheng Huat, executive director of PhAMA, the Malaysian association for innovative companies, describes the current market environment for innovative medicines in Malaysia, from the difficulties to enter the Malaysian…
Fabio Sperandei has been the country head for Sandoz Malaysia for four years. Here, he explains the key success factors that led Sandoz to become the leading multinational generic company…
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Smit Soni, Kalbe country manager for Malaysia and Singapore, explains the dynamics in the consumer healthcare market in Malaysia, and how Kalbe is ensuring that its products are being adapted…
See our Cookie Privacy Policy Here